Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liver carcinoma
|
942 | 0.683 | 0.400 | 17 | 7675143 | missense variant | C/A;T | snv | 4.0E-05 | 0.720 | 1.000 | 2 | 2011 | 2011 | |||||
Neoplastic Syndromes, Hereditary
|
6387 | 0.683 | 0.400 | 17 | 7675143 | missense variant | C/A;T | snv | 4.0E-05 | 0.700 | 1.000 | 13 | 1998 | 2011 | |||||
ovarian neoplasm
|
757 | 0.683 | 0.400 | 17 | 7675143 | missense variant | C/A;T | snv | 4.0E-05 | 0.700 | 0 | ||||||||
Breast Carcinoma
|
2793 | 0.683 | 0.400 | 17 | 7675143 | missense variant | C/A;T | snv | 4.0E-05 | 0.020 | 1.000 | 2 | 2008 | 2008 | |||||
Cutaneous Melanoma
|
248 | 0.683 | 0.400 | 17 | 7675143 | missense variant | C/A;T | snv | 4.0E-05 | 0.020 | 1.000 | 2 | 2013 | 2016 | |||||
Malignant neoplasm of breast
|
3417 | 0.683 | 0.400 | 17 | 7675143 | missense variant | C/A;T | snv | 4.0E-05 | 0.020 | 1.000 | 2 | 2008 | 2008 | |||||
melanoma
|
515 | 0.683 | 0.400 | 17 | 7675143 | missense variant | C/A;T | snv | 4.0E-05 | 0.020 | 1.000 | 2 | 2013 | 2016 | |||||
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C
|
82 | 0.683 | 0.400 | 17 | 7675143 | missense variant | C/A;T | snv | 4.0E-05 | 0.020 | 1.000 | 2 | 2013 | 2016 | |||||
Xeroderma pigmentosum, group F
|
31 | 0.683 | 0.400 | 17 | 7675143 | missense variant | C/A;T | snv | 4.0E-05 | 0.020 | 1.000 | 2 | 2013 | 2016 | |||||
Acute pancreatitis
|
51 | 0.683 | 0.400 | 17 | 7675143 | missense variant | C/A;T | snv | 4.0E-05 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Anaplastic thyroid carcinoma
|
16 | 0.683 | 0.400 | 17 | 7675143 | missense variant | C/A;T | snv | 4.0E-05 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Carcinoma of lung
|
1204 | 0.683 | 0.400 | 17 | 7675143 | missense variant | C/A;T | snv | 4.0E-05 | 0.010 | 1.000 | 1 | 2020 | 2020 | |||||
Cutaneous Mastocytosis
|
18 | 0.683 | 0.400 | 17 | 7675143 | missense variant | C/A;T | snv | 4.0E-05 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Diffuse Large B-Cell Lymphoma
|
127 | 0.683 | 0.400 | 17 | 7675143 | missense variant | C/A;T | snv | 4.0E-05 | 0.010 | 1.000 | 1 | 2007 | 2007 | |||||
Esophageal carcinoma
|
272 | 0.683 | 0.400 | 17 | 7675143 | missense variant | C/A;T | snv | 4.0E-05 | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||
Esophageal Neoplasms
|
270 | 0.683 | 0.400 | 17 | 7675143 | missense variant | C/A;T | snv | 4.0E-05 | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||
Malignant neoplasm of esophagus
|
214 | 0.683 | 0.400 | 17 | 7675143 | missense variant | C/A;T | snv | 4.0E-05 | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||
Malignant neoplasm of lung
|
1142 | 0.683 | 0.400 | 17 | 7675143 | missense variant | C/A;T | snv | 4.0E-05 | 0.010 | 1.000 | 1 | 2020 | 2020 | |||||
Peripheral T-Cell Lymphoma
|
10 | 0.683 | 0.400 | 17 | 7675143 | missense variant | C/A;T | snv | 4.0E-05 | 0.010 | 1.000 | 1 | 2007 | 2007 | |||||
Primary malignant neoplasm of lung
|
981 | 0.683 | 0.400 | 17 | 7675143 | missense variant | C/A;T | snv | 4.0E-05 | 0.010 | 1.000 | 1 | 2020 | 2020 | |||||
Sporadic Breast Carcinoma
|
46 | 0.683 | 0.400 | 17 | 7675143 | missense variant | C/A;T | snv | 4.0E-05 | 0.010 | 1.000 | 1 | 2004 | 2004 |